Erlotinib in Women With Squamous Cell Carcinoma of the Vulvar
Clinical trial NCT00476476 · COMPLETED
Trial details
- NCT number
- NCT00476476
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-01
- Primary completion
- 2012-10-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.